Search Results 1071-1080 of 15858 for syphilis

  1. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...

  2. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  3. Overview - Division of Clinical Trials and Biostatistics - Mayo Clinic Research

    Learn how Mayo Clinic's Division of Clinical Trials and Biostatistics provides high-value analytical collaborations and research services to investigators.

  4. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  6. A Study to Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) in Patients with Polycythemia Vera - Mayo Clinic

    The main purpose of this study is to evaluate the effectiveness of IONIS-TMPRSS6-LRx in reducing the frequency of phlebotomy and in improving quality of life ...

  7. Mortality and Adverse Outcomes in Liver Transplant - Mayo Clinic

    About this study. The primary aim of this study is to use an MRI-based Muscle Assessment Score (MAsS), which includes both muscle volume and fat ...

  8. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...

  9. centers-of-excellence

    Centers and Programs Center for Clinical and Translational Science (CCaTS) Education Overview Education Education Overview Certificate Program Clinical Trialist ...

  10. Publications - Jacob C. Jentzer, M.D. - Mayo Clinic

    Roston TM, Aghanya V, Savu A, Fordyce CB, Lawler PR, Jentzer J, Wong GC, Brunham LR, Senaratne J, van Diepen S, Kaul P. Premature Acute Myocardial ...